Clinical Trial Update: Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant letrozole in combination with chemotherapy for estrogen receptor-positive, HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Breast Cancer, Invasive Breast Cancer | Phase 2 | Status: UNKNOWN